Effect of Pre-Hospital ARNI Therapy on Short-Term Outcomes in HFrEF
ConditionHeart Failure
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFuture University in Egypt
About this trial
This study looks at people with heart failure who are admitted to the hospital. The goal of the study is to understand whether taking a heart failure medicine called angiotensin receptor-neprilysin inhibitor (ARNI) before hospital admission affects short-term health outcomes.
The study will compare two groups of participants: those who were already taking ARNI before coming to the hospital and those who were not. Information will be collected from medical records during the hospital stay, including heart-related events, kidney-related events, and how long participants stay in the hospital.
Some participants will also be followed for a short period after discharge. This study may help improve understanding of outcomes associated with ARNI use in people with heart failure in routine clinical care.
Eligibility criteria
Qualifiers
>= 18 years, male or female EF <40%
Disqualifiers
EF>40% Pregnancy or breastfeeding
Trial design
Treatments tested in this trial
- Prehospital ARNI use
- No prehospital ARNI use
Treatment groups
140 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov